Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endogenous opioids and their receptors.

H W Kosterlitz1

  • 1Unit for Research on Addictive Drugs, University of Aberdeen, Marischal College, U.K.

Polish Journal of Pharmacology and Pharmacy
|September 1, 1987
PubMed
Summary

Developing selective opioid receptor antagonists is crucial for understanding opioid peptide functions. Research focuses on creating compounds that target specific receptors and inhibit peptidases involved in opioid signaling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assay of the biological value of a protein by its effect on liver cytoplasm.

Nature·2010
Same author

Dietary protein and histological structure of liver tissue.

The Journal of physiology·2010
Same author

The effects of changes in dietary protein on the composition and structure of the liver cell.

The Journal of physiology·2010
Same author

Ribonucleic acid as a constituent of labile liver cytoplasm.

The Journal of physiology·2010
Same author

A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. 1972.

British journal of pharmacology·1997
Same author

The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. 1977.

British journal of pharmacology·1997

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Endogenous opioid peptides interact with multiple receptor types (mu, delta, kappa).
  • Existing synthetic opioid agonists show high receptor selectivity.
  • Selective opioid receptor antagonists are needed to elucidate receptor-specific functions.

Purpose of the Study:

  • To highlight the necessity for developing selective opioid receptor antagonists.
  • To emphasize the importance of understanding peptidase roles in opioid transmission.
  • To underscore the need for methods to study endogenous opioid peptide release.

Main Methods:

  • Review of current literature on opioid receptor ligands.
  • Discussion of the physiological basis for correlating receptor binding with pharmacological effects.
  • Consideration of peptidase inhibitors and methods for studying peptide release.

Main Results:

  • Selective opioid agonists are available, but selective antagonists are still required.
  • Selective ligands will enable correlation of receptor binding with pharmacological effects.
  • Peptidase inhibitors are necessary to prevent degradation of opioid peptides.
  • Methods for studying endogenous opioid peptide release are needed.

Conclusions:

  • Selective opioid receptor antagonists are essential for advancing opioid research.
  • Development of peptidase inhibitors and release-studying methods will enhance understanding of opioid systems.

Related Experiment Videos